Optimization of a spectrofluorimetric method based on a central composite design for the determination of potassium losartan in pharmaceutical products
Here, a spectrofluorimetric method for the determination of potassium losartan (PL) in pharmaceutical products is described. The effects of critical parameters, pH, acid molarity, and temperature, on the fluorescence intensity of PL were analyzed, and these parameters were optimized using a central...
Saved in:
Main Authors: | Fatma Demirkaya-Miloglu (Author), Mehmet Emrah Yaman (Author), Yucel Kadioglu (Author) |
---|---|
Format: | Book |
Published: |
Universidade de São Paulo,
2014-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Spectrofluorimetric determination of amlodipine in human plasma without derivatization
by: Yucel Kadioglu, et al.
Published: (2012) -
Optimized and Validated RP-UPLC Method for the Determination of Losartan Potassium and Chlorthalidone in Pharmaceutical Formulations
by: Tadiboyina Sirisha, et al.
Published: (2015) -
Pharmaceutical Development of Film-Coated Mini-Tablets with Losartan Potassium for Epidermolysis Bullosa
by: Valentinë Elezaj, et al.
Published: (2022) -
Validated spectrofluorimetric method for the determination of atorvastatin in pharmaceutical preparations
by: Mohie M.K. Sharaf El-Din, et al.
Published: (2012) -
Degradation kinetics and characterization of degradation products of losartan potassium by LC-MS/MS method
by: Dobričić Vladimir, et al.
Published: (2019)